These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31126327)

  • 1. A retrospective study on the influence of siblings' relatedness in Bolivian patients with chronic Chagas disease.
    Espinosa-Pereiro J; Sánchez-Montalvá A; Salvador F; Sao-Avilés A; Sulleiro E; Molina I
    Parasit Vectors; 2019 May; 12(1):260. PubMed ID: 31126327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole.
    Ann Intern Med; 2006 May; 144(10):I32. PubMed ID: 16702585
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
    Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A
    Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdisciplinary approach at the primary healthcare level for Bolivian immigrants with Chagas disease in the city of São Paulo.
    Shikanai Yasuda MA; Sátolo CG; Carvalho NB; Atala MM; Ferrufino RQ; Leite RM; Furucho CR; Luna E; Silva RA; Hage M; de Oliveira CMR; Busser FD; de Freitas VLT; Wanderley DM; Martinelli L; Almeida SR; Viñas PA; Carneiro N
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005466. PubMed ID: 28333923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
    Morillo CA; Marin-Neto JA; Avezum A; Sosa-Estani S; Rassi A; Rosas F; Villena E; Quiroz R; Bonilla R; Britto C; Guhl F; Velazquez E; Bonilla L; Meeks B; Rao-Melacini P; Pogue J; Mattos A; Lazdins J; Rassi A; Connolly SJ; Yusuf S;
    N Engl J Med; 2015 Oct; 373(14):1295-306. PubMed ID: 26323937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
    Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic.
    Pinazo MJ; Cañas E; Elizalde JI; García M; Gascón J; Gimeno F; Gomez J; Guhl F; Ortiz V; Posada Ede J; Puente S; Rezende J; Salas J; Saravia J; Torrico F; Torrus D; Treviño B
    Gastroenterol Hepatol; 2010 Mar; 33(3):191-200. PubMed ID: 19837482
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
    Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
    Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
    Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
    Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
    Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi.
    Santos FM; Mazzeti AL; Caldas S; Gonçalves KR; Lima WG; Torres RM; Bahia MT
    Acta Trop; 2016 Sep; 161():44-54. PubMed ID: 27215760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood.
    Fernández ML; Hernández Y; Scollo K; Esteva MI; Riarte AR; Prado NG
    Rev Soc Bras Med Trop; 2018; 51(4):557-559. PubMed ID: 30133646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of Chagasic Cardiomyopathy Is Associated With Response to a Novel Rapid Diagnostic Test for Trypanosoma cruzi TcII/V/VI.
    Bhattacharyya T; Messenger LA; Bern C; Mertens P; Gilleman Q; Zeippen N; Bremer Hinckel BC; Murphy N; Gilman RH; Miles MA;
    Clin Infect Dis; 2018 Aug; 67(4):519-524. PubMed ID: 29438471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Chagas disease: Quantification of Trypanosoma cruzi in peripheral blood and dejections of Triatoma infestans fed by xenodiagnosis in patients with and without cardiopathy.
    Apt W; Carrasco D; Fuentealba C; Canals M; Muñoz G; Saavedra M; Castillo JP; Zulantay I
    Acta Trop; 2019 Dec; 200():105167. PubMed ID: 31513762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.